Phase I study of docetaxel (D) in combination with epirubicin (E) as first line chemotherapy in metastatic breast cancer

被引：0
|
作者：
Borquez, D
Raab, G
Harstrick, A
Wilke, HJ
Achterrath, W
Eiermann, W
Seeber, S
机构：
[1] Rot Kreuz Hosp, Munich, Germany
[2] W German Canc Ctr, Essen, Germany
[3] Rhone Poulenc Rorer, Cologne, Germany
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [1] Phase II study of weekly epirubicin and docetaxel as first line chemotherapy in metastatic breast cancer
    Gamucci, Teresa
    D'Ottavio, Anna Maria
    Gareri, Roberta
    Vaccaro, Angela
    Belli, Franca
    Nunziata, Corrado
    Meliffi, Loretta
    Moscetti, Luca
    Barduagni, Mario
    Sperduti, Isabella
    ANNALS OF ONCOLOGY, 2004, 15 : 48 - 49
  • [2] Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
    P A Vasey
    H Roché
    D Bisset
    C Terret
    L Vernillet
    A Riva
    C Ramazeilles
    N Azli
    S B Kaye
    C J Twelves
    British Journal of Cancer, 2002, 87 : 1072 - 1078
  • [3] Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
    Vasey, PA
    Roché, H
    Bisset, D
    Terret, C
    Vernillet, L
    Riva, A
    Ramazeilles, C
    Azli, N
    Kaye, SB
    Twelves, CJ
    BRITISH JOURNAL OF CANCER, 2002, 87 (10) : 1072 - 1078
  • [4] Phase I intrapatient dose escalation study of weekly epirubicin and docetaxel as first line chemotherapy in metastatic breast cancer
    Lo, N.
    Ayers, S.
    Catell, E.
    Koetzl, B.
    Singh, N.
    Alexander, G.
    Lowe, F.
    Rea, D. W.
    EJC SUPPLEMENTS, 2004, 2 (03): : 133 - 133
  • [5] Docetaxel with epirubicin as first line chemotherapy in metastatic breast cancer (MBC).: Final results of a Phase II study
    Morales, S
    Lorenzo, A
    Ramos, M
    Ballesteros, P
    Méndez, M
    Almanza, C
    Moreno-Nogueira, J
    Casal, J
    Castellanos, J
    Lizón, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S68 - S68
  • [6] WEEKLY EPIRUBICIN AND DOCETAXEL AS FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
    D'Ottavio, A.
    Vaccaro, A.
    Belli, F.
    Nunziata, C.
    Meliffi, L.
    Moscetti, L.
    Barduagni, M.
    Sperduti, I.
    Gamucci, T.
    ANNALS OF ONCOLOGY, 2004, 15 : 19 - 19
  • [7] Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer
    Venturini, M
    Del Mastro, L
    Garrone, O
    Angiolini, C
    Merlano, M
    Bergaglio, M
    Tolino, G
    Lambiase, A
    Baldini, A
    Canavese, G
    Rosso, R
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 546 - 552
  • [8] A phase I study of the combination of docetaxel (D) and adriamicin (AD) in first line CT treatment of metastatic breast cancer (MBC)
    Dieras, V
    Gruia, G
    Pouillart, P
    Cvitkovic, E
    Gentin, M
    Azli, N
    Riva, A
    Misset, JL
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 935 - 935
  • [9] Combination of docetaxel and doxorubicin as first-line chemotherapy in metastatic breast cancer
    Baltali, E
    Özisik, Y
    Güler, N
    Firat, D
    Altundag, K
    TUMORI, 2001, 87 (01) : 18 - 19
  • [10] A phase I dose-finding study of capecitabine in combination with epirubicin and docetaxel as first-line chemotherapy in advanced breast cancer patients.
    Angiolini, C
    Venturini, M
    Del Mastre, L
    Bergaglio, M
    Garrone, O
    Merlano, M
    Tolino, G
    Lambiase, A
    Bighin, C
    Stevani, I
    Catzeddu, T
    Bertelli, G
    Rosso, R
    ANNALS OF ONCOLOGY, 2000, 11 : 36 - 36
12345